LKFT at a glance
Lakefront Biotherapeutics NV (LKFT, SEC CIK 1421876) filed its latest 20-F annual report on March 26, 2026 and a 6-K report on November 18, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- As of September 30, 2026, 16 institutional investment managers tracked by SignalX reported holding Lakefront Biotherapeutics NV (LKFT) shares worth $555.9 million in 13F-HR filings.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 16 funds
- $555.9M · −1 vs prior quarter
- Latest 6-K
- Nov 18, 2026
- Foreign issuer report
SignalX for LKFT
Don't miss the next LKFT filing
- Alerts as it files. A push when LKFT files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut LKFT, by share count.
- Ask anything. An AI agent that reads every LKFT filing and answers with sources.
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate LKFT share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 16 | $555.9M |
| Q2 2026 | 17 | $580.3M |
| Q1 2026 | 17 | $579.9M |
| Q4 2025 | 16 | $648.2M |
| Q3 2025 | 16 | $672.8M |
| Q2 2025 | 15 | $548.1M |
| Q1 2025 | 13 | $475.7M |
| Q4 2024 | 8 | $518.7M |
- Citadel Advisors LLC+224.3K (+254%)
- D.E. Shaw & Co+127.8K (+65%)
- Two Sigma Investments+85.5K (+105%)
- Goldman Sachs Group+83.9K (+148%)
- BlackRock+55.9K (+17%)
- Ameriprise Financial−1.26M (-99%)
- Millennium Management−163.5K (-90%)
- Bank of America Corp−60 (-1%)
- JPMorgan Chase & Co−31 (-2%)
Source: 13F-HR filings on SEC EDGAR (aggregated from 118 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
Latest 2026 SEC Filings: 20-F, 6-K
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 6-K | Nov 18, 2026 | - | - | - |
| 6-K | Nov 16, 2026 | - | - | - |
| 6-K | Nov 12, 2026 | - | - | - |
| 6-K | Nov 12, 2026 | - | - | - |
| 6-K | Nov 4, 2026 | - | - | - |
| 6-K | Nov 2, 2026 | - | - | - |
| 6-K | Oct 20, 2026 | - | - | - |
| 6-K | Oct 15, 2026 | - | - | - |
| 6-K | Oct 13, 2026 | - | - | - |
| 6-K | Oct 9, 2026 | - | - | - |
| 6-K | Oct 6, 2026 | - | - | - |
| 6-K | Sep 29, 2026 | - | - | - |
| 6-K | Sep 23, 2026 | - | - | - |
| 6-K | Sep 15, 2026 | - | - | - |
| 6-K | Sep 8, 2026 | - | - | - |
| 6-K | Sep 8, 2026 | - | - | - |
| 6-K | Sep 1, 2026 | - | - | - |
| 6-K | Aug 25, 2026 | - | - | - |
| 6-K | Aug 25, 2026 | - | - | - |
| 6-K | Aug 25, 2026 | - | - | - |
| 6-K | Aug 18, 2026 | - | - | - |
| 6-K | Aug 12, 2026 | - | - | - |
| 6-K | Aug 12, 2026 | - | - | - |
| 6-K | Aug 4, 2026 | - | - | - |
| 6-K | Jul 28, 2026 | - | - | - |
Related Health Care companies
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
- ABEO · ABEONA THERAPEUTICS INC.Pharmaceutical Preparations
- ACAD · ACADIA PHARMACEUTICALS INCPharmaceutical Preparations
- ACRS · Aclaris Therapeutics, Inc.Pharmaceutical Preparations
- ACTU · ACTUATE THERAPEUTICS, INC.Pharmaceutical Preparations
- ADCT · ADC Therapeutics SAPharmaceutical Preparations
LKFT SEC filings: frequently asked questions
Which institutions hold LKFT stock?
As of September 30, 2026, the largest Lakefront Biotherapeutics NV (LKFT) holders among the 13F filers tracked by SignalX were Gilead Sciences ($501.3 million), Renaissance Technologies LLC ($12.6 million), BlackRock ($11.7 million), D.E. Shaw & Co ($9.7 million), Citadel Advisors LLC ($9.3 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What are the latest LKFT SEC filings?
Lakefront Biotherapeutics NV (LKFT) filed its latest 20-F annual report on March 26, 2026 and a 6-K report on November 18, 2026.
What is LKFT's SEC CIK number?
Lakefront Biotherapeutics NV (LKFT)'s SEC Central Index Key (CIK) is 1421876. EDGAR lists every LKFT filing under that number.
Ask anything about LKFT
The research agent reads LKFT's filings, financials, insider trades and 13F holders, then answers with sources.